CDK6 and acute myeloid leukemia: When tested in CDK6‐dependent AML cell lines, PROTAC BSJ caused a significant antiproliferative effect by inducing G1 cell‐cycle arrest, yet without an increase in the number of apoptotic cells.138, 150